XWARNVT
Market cap68mUSD
Dec 23, Last price
113.00PLN
1D
-2.59%
1Q
1.35%
Jan 2017
72.52%
Name
Novita SA
Chart & Performance
Profile
Novita S.A. engages in the manufacture and sale of nonwovens worldwide. The company offers spunlace and needlepunched; medical and hygiene; shoe and clothing; geononwovens; and private label, as well as other nonwovens, such as leathercraft and loudspeaker under the Unitex brand name. Its products are used in the personal hygiene, industrial, and household sectors, as well as in the medical, construction, and footwear industries. Novita S.A. also provides office and warehouse areas for rent. The company was incorporated in 2001 and is based in Zielona Góra, Poland. Novita S.A. is a subsidiary of Tebesa Sp. z o.o.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 184,895 -25.70% | 248,849 12.39% | 221,425 10.19% | |||||||
Cost of revenue | 164,538 | 221,342 | 160,854 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 20,357 | 27,507 | 60,571 | |||||||
NOPBT Margin | 11.01% | 11.05% | 27.36% | |||||||
Operating Taxes | 4,727 | 4,198 | 11,279 | |||||||
Tax Rate | 23.22% | 15.26% | 18.62% | |||||||
NOPAT | 15,630 | 23,309 | 49,292 | |||||||
Net income | 23,286 8.97% | 21,369 -57.06% | 49,759 22.29% | |||||||
Dividends | (40,000) | (53,000) | ||||||||
Dividend yield | 12.80% | 12.93% | ||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 28 | 27 | 10,291 | |||||||
Long-term debt | 9,846 | 9,901 | 9,954 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 188 | 191 | 226 | |||||||
Net debt | 1,124 | 271 | 12,475 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 35,922 | 14,294 | 54,042 | |||||||
CAPEX | (3,035) | (1,688) | (2,607) | |||||||
Cash from investing activities | (2,905) | (1,688) | (842) | |||||||
Cash from financing activities | (33,941) | (10,734) | (48,003) | |||||||
FCF | 30,373 | 12,331 | 52,218 | |||||||
Balance | ||||||||||
Cash | 8,749 | 9,656 | 7,769 | |||||||
Long term investments | 1,000 | 1,000 | 1,000 | |||||||
Excess cash | ||||||||||
Stockholders' equity | 66,074 | 64,180 | 125,876 | |||||||
Invested Capital | 135,644 | 150,301 | 129,499 | |||||||
ROIC | 10.93% | 16.66% | 37.62% | |||||||
ROCE | 13.95% | 17.17% | 43.89% | |||||||
EV | ||||||||||
Common stock shares outstanding | 2,500 | 2,500 | 2,500 | |||||||
Price | 125.00 35.28% | 92.40 -43.66% | 164.00 26.15% | |||||||
Market cap | 312,500 35.28% | 231,000 -43.66% | 410,000 26.15% | |||||||
EV | 313,624 | 231,271 | 422,475 | |||||||
EBITDA | 25,031 | 32,249 | 65,672 | |||||||
EV/EBITDA | 12.53 | 7.17 | 6.43 | |||||||
Interest | 266 | 442 | 331 | |||||||
Interest/NOPBT | 1.31% | 1.61% | 0.55% |